280 related articles for article (PubMed ID: 33139977)
1. Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations.
Ma Y; Teng Q; Zhang Y; Zhang S
Intractable Rare Dis Res; 2020 Nov; 9(4):187-195. PubMed ID: 33139977
[TBL] [Abstract][Full Text] [Related]
2. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
Bonkovsky HL; Dixon N; Rudnick S
Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
[TBL] [Abstract][Full Text] [Related]
4. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria.
D'Avola D; López-Franco E; Sangro B; Pañeda A; Grossios N; Gil-Farina I; Benito A; Twisk J; Paz M; Ruiz J; Schmidt M; Petry H; Harper P; de Salamanca RE; Fontanellas A; Prieto J; González-Aseguinolaza G
J Hepatol; 2016 Oct; 65(4):776-783. PubMed ID: 27212246
[TBL] [Abstract][Full Text] [Related]
5. Acute intermittent porphyria: a test of clinical acumen.
Dhital R; Basnet S; Poudel DR; Bhusal KR
J Community Hosp Intern Med Perspect; 2017 Mar; 7(2):100-102. PubMed ID: 28638573
[TBL] [Abstract][Full Text] [Related]
6. Novel A219P mutation of hydroxymethylbilane synthase identified in a Chinese woman with acute intermittent porphyria and syndrome of inappropriate antidiuretic hormone.
Li Y; Qu H; Wang H; Deng H; Liu Z
Ann Hum Genet; 2015 Jul; 79(4):310-2. PubMed ID: 25787008
[TBL] [Abstract][Full Text] [Related]
7. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
[TBL] [Abstract][Full Text] [Related]
8. Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis.
Alfadhel M; Saleh N; Alenazi H; Baffoe-Bonnie H
Neuropsychiatr Dis Treat; 2014; 10():2135-7. PubMed ID: 25419136
[TBL] [Abstract][Full Text] [Related]
9. Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.
Unzu C; Sampedro A; Sardh E; Mauleón I; Enríquez de Salamanca R; Prieto J; Salido E; Harper P; Fontanellas A
PLoS One; 2012; 7(3):e32978. PubMed ID: 22412963
[TBL] [Abstract][Full Text] [Related]
10. Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria.
Morán-Jiménez MJ; Borrero-Corte MJ; Jara-Rubio F; García-Pastor I; Díaz-Díaz S; Castelbón-Fernandez FJ; Enríquez-de-Salamanca R; Méndez M
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806544
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
Kauppinen R; von und zu Fraunberg M
Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973
[TBL] [Abstract][Full Text] [Related]
12. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.
Solares I; Jericó D; Córdoba KM; Morales-Conejo M; Ena J; Enríquez de Salamanca R; Fontanellas A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613492
[TBL] [Abstract][Full Text] [Related]
13. Acute Intermittent Porphyria: Complete Phenotype in a Patient with p.Arg173Trp Variant in Thailand.
Sriprakoon V; Ittagornpunth C; Puapaiboon N; Bunyahathaipat A; Piriyanon P; Khositseth S; Rojnueangnit K
Am J Case Rep; 2022 Nov; 23():e937695. PubMed ID: 36329616
[TBL] [Abstract][Full Text] [Related]
14. Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
Molina L; Zhu J; Trépo E; Bayard Q; Amaddeo G; ; Blanc JF; Calderaro J; Ma X; Zucman-Rossi J; Letouzé E
J Hepatol; 2022 Oct; 77(4):1038-1046. PubMed ID: 35636578
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in vascular reactivity in mesenteric arteries from a mouse model of acute intermittent porphyria.
Pulgar VM; Yasuda M; Gan L; Desnick RJ; Bonkovsky HL
Mol Genet Metab; 2019 Nov; 128(3):376-381. PubMed ID: 30639047
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
[TBL] [Abstract][Full Text] [Related]
17. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
[TBL] [Abstract][Full Text] [Related]
18. Acute Intermittent Porphyria's Symptoms and Management: A Narrative Review.
Kizilaslan EZ; Ghadge NM; Martinez A; Bass M; Winayak R; Mathew M; Amin R; Khan M; Kizilbash N
Cureus; 2023 Mar; 15(3):e36058. PubMed ID: 37065381
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
